• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

Ypsomed completes sale of diabetes care business to TecMed

August 4, 2025 By Sean Whooley

Ypsomed TecMed

Ypsomed announced today that it successfully completed the sale of its diabetes care business to TecMed AG. Burgdorf, Switzerland–based Ypsomed in April announced its plans to sell the business to help focus on strengthening its position in the subcutaneous self-injection market. TecMed — also based in Burgdorf — can now add Ypsomed’s insulin delivery technology […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Mergers & Acquisitions, Technology Tagged With: TecMed, Ypsomed

Trividia Health launches new insulin pen needles in the UK

August 1, 2025 By Sean Whooley

Trividia Health TruePlus five-bevel tip (1)

Trividia Health announced today that it launched its new TRUEplus five-bevel insulin pen needle line in the UK. The new five-bevel pen needle provides healthcare providers with a variety of different needle gauges and sizes at low cost for patients with diabetes. Trividia designed the needles for maximum comfort, delivering high quality, safety and ease […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations Tagged With: Trividia Health

Boston Scientific earns Medicare reimbursement for Agent drug-coated balloon

August 1, 2025 By Sean Whooley

Boston Scientific Agent drug-coated balloon DCB

Boston Scientific (NYSE: BSX) announced today that CMS granted reimbursement for its Agent drug-coated balloon (DCB). CMS granted a new technology add-on payment (NTAP) for eligible cases using Agent. NTAP provides additional reimbursement to hospitals that use designated new medical technologies in the first few years of market introduction. Starting Oct. 1, 2025, CMS intends […]

Filed Under: Business/Financial News, Cardiovascular, Drug-Device Combinations Tagged With: Boston Scientific, Centers for Medicare and Medicaid Services (CMS)

The 10 largest diabetes technology companies in the world

July 31, 2025 By Sean Whooley

10 largest diabetes tech companies in the world

What has changed in the last year as diabetes technology developers continue to innovate and advance their offerings? We are seeing the industry form an intriguing niche at the intersection of medtech and consumer devices. Various companies around the world are delivering numerous options when it comes to the type of technology they want to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: abbott, Beta Bionics, Dexcom, embecta, Insulet, Medtronic, minimed, Roche, Roche Diabetes Care, Senseonics, Tandem Diabetes Care, Ypsomed

Sava raises $19M to advance glucose biosensor

July 31, 2025 By Sean Whooley

Sava Technologies glucose biosensor

Sava Technologies announced today that it raised $19 million in a Series A financing round to support its wearable biosensor technology. Balderton Capital and Pentland Ventures led the round, with new investors Norrsken VC and JamJar Investments joining, too. Other investors included True, Italian Founders Fund, Athletico Ventures, SOLO Investments and Exceptional Ventures. The funding […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Patient Monitoring, Technology Tagged With: Sava Technologies

Dexcom beats Street in Q2, raises guidance as it plans for 15-day G7 launch this year

July 30, 2025 By Sean Whooley

Dexcom updated Logo

Dexcom (Nadsaq:DXCM) today reported second-quarter financial results that came in ahead of the consensus forecast. The company also announced a planned CEO transition — read more about that HERE. Shares of DXCM sat unchanged at $89.06 apiece in post-market trading today. (They fell by more than 9% the next day, July 31, to $80.88 apiece.) […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

Dexcom to promote COO Jake Leach to CEO, succeeding Kevin Sayer

July 30, 2025 By Sean Whooley

Jake Leach Dexcom COO

Dexcom (Nadsaq:DXCM) announced today that Jake Leach will succeed Kevin Sayer as CEO, effective Jan. 1, 2026. Leach, the company’s president and COO, will take over the corner office as part of the company’s planned succession process. Sayer, who served in the CEO role for more than a decade after assuming the post in January […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Personnel, Technology Tagged With: Dexcom, Personnel Moves

Beta Bionics stock gets a boost on Q2 results, raised guidance

July 29, 2025 By Sean Whooley

Beta Bionics Logo (1)

Beta Bionics (Nasdaq:BBNX) shares rose after hours today on raised 2025 guidance and second-quarter results that beat the consensus forecast. The company increased its 2025 guidance for revenues between $88 million and $93 million. It previously projected between $82 million and $87 million. Shares of BBNX ticked up nearly 5% to $15.35 apiece in post-market […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Beta Bionics

Tidepool launches cloud integration with Abbott CGM

July 29, 2025 By Sean Whooley

Tidepool Abbott

Tidepool announced that it began rolling out its new cloud-to-cloud integration with the Abbott (NYSE:ABT) FreeStyle Libre CGM portfolio. In October 2024, the companies announced a collaboration to deliver cloud-to-cloud integration for an automatic stream of data for patients using Abbott continuous glucose monitors (CGMs) in the U.S. “Every day at Tidepool, we work to […]

Filed Under: Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, tidepool

Dexcom launches AI-powered meal logging for CGM users

July 28, 2025 By Sean Whooley

Dexcom Stelo CGM AI Smart Food Logging Feature (1)

Dexcom (Nadsaq:DXCM) announced today that it released a new AI-powered photo meal logging feature for its Stelo platform. Stelo, the first FDA-cleared over-the-counter glucose biosensor, joins the G7 continuous glucose monitor (CGM) in offering this new feature. Smart Food Logging encourages and enables users to log meals more consistently through the use of just a […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Interim pages omitted …
  • Page 192
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS